-
Annexin V-PE Reagent for CD38 CAR Apoptosis
2026-09-22
Connect CD38 CAR design with a rapid, fluorescence-based readout of phosphatidylserine exposure, target-cell killing, and potential fratricide. This workflow combines flow cytometry or microscopy with practical controls to distinguish early apoptotic events from late membrane failure.
-
Propidium Iodide: A Better Read of Cell Damage
2026-09-22
Propidium iodide is a DNA intercalating dye whose signal reports membrane accessibility as much as nuclear content. This guide develops a pre-analytical framework for cell viability assay, apoptosis detection, and cell cycle analysis, using recent protein-processing research to improve interpretation.
-
CNO and the Logic of Pain-Circuit Causality
2026-09-21
Clozapine N-oxide provides a strategic chemogenetic route for testing how the parabrachial–hypothalamic–spinal opioid pathway controls mechanical hypersensitivity and tolerance, while emphasizing the controls required for translational confidence.
-
DAPT (GSI-IX): γ-Secretase Research Guide
2026-09-21
DAPT, also called GSI-IX, is a selective γ-secretase inhibitor that reduces amyloid-β generation and Notch substrate processing in cellular models. This guide summarizes its mechanism, quantitative product benchmarks, experimental uses, handling parameters, and interpretation limits.
-
Ferrocenyl Novobiocin Derivatives: Study Insights
2026-09-20
The reference study developed novobiocin analogues that replace a hydrophobic benzamide-side-chain region with ferrocene and compared them with matched organic derivatives. In vitro testing against Plasmodium falciparum and breast cancer cells indicated that ferrocene incorporation generally improved biological activity, supporting bioorganometallic modification as a strategy for future structure–activity studies.
-
CGF, ROS, and Cell-Cycle Control in Colorectal Cancer
2026-09-19
A 2026 iScience study identifies Cya-Gly-Fer (CGF), a natural anthocyanin derivative from purple sweet potato, as an inhibitor of colorectal cancer growth and metastasis. Its integrated cell, organoid, xenograft, transcriptomic, and metabolomic analyses connect ABC transporter disruption with ATP accumulation, mitochondrial dysfunction, ROS overload, MAPK/ERK1/2/c-MYC suppression, cell-cycle arrest, and apoptosis.
-
IGFBP2–THBS1 Axis in GH-Mediated Bone Growth
2026-09-18
The reference study identifies an IGFBP2–THBS1 regulatory axis that links growth hormone treatment to IGF-1 signaling in chondrocytes from an idiopathic short stature research model. Its combination of patient plasma data, bioinformatic interaction prediction, and gain- and loss-of-function experiments provides a mechanistic framework for understanding variable responses to GH therapy, while also highlighting the need for in vivo validation.
-
Gepotidacin: Designing Mechanism-Led Assays
2026-09-18
Gepotidacin, also known as GSK2140944, is best studied through a layered workflow connecting topoisomerase biochemistry to cellular susceptibility. This article develops an assay-design framework informed by antibiotic production engineering, resistance research, and orthogonal DNA damage readouts.
-
Propidium Iodide for Cell Viability and DNA Analysis
2026-09-17
Use Propidium iodide as a membrane-integrity readout, a late-apoptosis companion stain, or a DNA-content probe after controlled permeabilization. This practical guide connects PI workflow design with the reference study’s warning that short-term viability differences should not be overinterpreted as evidence of a universal cancer-cell mechanism.
-
7-AAD Analytics for CD38 CAR-T Translation
2026-09-17
Structural studies of CD38 CAR binders show why affinity, epitope geometry, and cellular selectivity must be optimized together. This article explains how membrane-integrity measurements using 7-AAD can translate those design principles into interpretable CAR-T potency, fratricide, and culture-quality data, while clarifying what the assay can—and cannot—conclude about mechanism.
-
mRNA-Loaded Dendritic Cells in Resected Melanoma
2026-09-16
This single-center pilot study evaluated autologous dendritic cells electroporated with multiple melanoma-antigen mRNAs after complete metastasis resection, with interferon alfa-2b used in different treatment schedules. More than six years of follow-up showed manageable toxicity and encouraging descriptive overall-survival rates, but the nonrandomized design prevents attribution of benefit to the mRNA-loaded cells alone.
-
JNJ-26481585 (Quisinostat) Workflow Guide
2026-09-16
Translate Quisinostat’s potent HDAC inhibition into measurable chromatin, apoptosis, proliferation, and drug-resistance endpoints. This workflow connects TRIM21–ERK1/2 biology with practical cell-based assays while emphasizing solvent control, timing, and orthogonal validation.
-
Annexin V for Time-Resolved Cell Death
2026-09-15
Annexin V is a calcium-dependent phosphatidylserine binding protein that can reveal cell-death timing before DNA fragmentation is readily measurable. This article explains how to translate phosphatidylserine externalization into better apoptosis assay design, controls, and interpretation using recombinant human Annexin V.
-
AT13387 Workflows for Hsp90 Inhibition
2026-09-15
AT13387 supports quantitative Hsp90 inhibition studies that connect client-protein loss with cell cycle arrest and apoptosis induction. This workflow also shows how findings on NINJ1-dependent secretion can improve assay design without overstating evidence for antiviral applications.
-
MMP-2-Responsive Liposomes for Breast Cancer Immunotherapy
2026-09-14
The reference study developed an MMP-2-responsive, cascade-targeted liposome that sequentially delivers the PD-1 pathway-blocking peptide AUNP-12 and the IDO inhibitor NLG919. Its design links tumor accumulation, PD-L1-associated targeting, protease-triggered peptide release, and secondary tumor-cell targeting to remodel an immunosuppressive breast cancer microenvironment.